Treace Medical Concepts Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $205.3M-1.9% YoYTTM through 30 Jun 2026
Net Income -$59.5MTTM through 30 Jun 2026
Free Cash Flow -$25MTTM through 30 Jun 2026
Margins
| Current | |
|---|---|
| Gross Margin | 79.3% |
| EBITDA Margin | -22.1% |
| Operating Margin | -36.4% |
| Net Margin | -29.0% |
Returns
-66.9%ROE
-17.9%ROA
Balance Sheet Health
Debt / Equity0.93x
Current Ratio4.31x
Net Debt$19.8M
Cash & Equivalents$12.6M
Quality Metrics
Altman Z-Score0.07
Piotroski F-Score1 / 9
FCF Margin-12.2%
Rule of 40-11.7
Earnings-Beat Rate100.0%
Multi-Year Trend
RevenueFY2025: $212.7M
Diluted EPS-$0.92TTMFY2025: $-0.93
Dividend
No dividend
Capital Allocation
R&D Spend$18.2M
Capex Intensity5.1%
Segment Performance
No segment data available.
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.